-+ 0.00%
-+ 0.00%
-+ 0.00%

AMYLYX PHARMACEUTICALS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $40 FROM $28

Reuters·08/19/2026 03:56:22

Please log in to view news